Covid-19 Update: TL records 1 new case, 7 recoveries

Covid-19 Update: TL records 1 new case, 7 recoveries

DILI, 15 november 2021 (TATOLI) – In the past 24 hours, Timor-Leste recorded one new COVID-19 case, seven recoveries, and the active cases dropped to six, said Rui Maria de Araujo, the Coordinator of the Integrated Crisis Management Center (SIJK).

The new case was detected in Bobonaro, one of the municipalities in the western part of the country.

There are two people with the mild condition of COVID-19 in hospital.

In the past 24 hours, the National Health Laboratory (LNS) has performed 113 PCR tests, including eight through random screening, 96 for the international travel authorization, and nine in quarantines.

The SIJK kept calling on communities to practice the health and safety guidelines recommended by the Ministry of Health (MoH) and the WHO to continue combating the spread of the virus.

Since Timor-Leste’s outbreak began in April 2020, the country has recorded 19.810 cases, 19.682 recoveries, 122 deaths.

In Timor-Leste, of the 754.864 adult group, 77.4 percent had received at least one dose of the COVID-19 vaccine, of which 52 percent have been fully vaccinated.

Covid-19 vaccination: Municipality Tracker 

At least four municipalities have now fully vaccinated more than 60 percent of their adult residents. Four of these municipalities – Dili (74.6%), Covalima (63.4%), and Viqueque (61.5%) and RAEAO (60.9%). However, the vaccination rate is low in Ermera and Liquica with 28.1% and 36.2 %t respectively.

So far, Timor-Leste had received a total of 1.213.279 doses of Covid-19 vaccines, consisting of 1.012.650 doses of AstraZeneca, 100.000 doses of SINOVAC (China), and 100.620 doses of Pfizer vaccines (USA).

Of the 1.012.650 AstraZeneca Covid-19 vaccines, 100.800 doses were given by COVAX Facility, 24.00 doses from New Zealand, 577.850 does were donated by the government of Australia, 142.000 doses from Portugal, and 168.000 doses were given by the Japanese government.

Journalist: Filomeno Martins

Editor: Nelia Borges Rosario


Leave a Reply

error: Content is protected !!